4-Fluoro-3-[(trifluoromethyl)sulfonyl]benzenesulfonamide
- CAS1027345-08-9
- CatalogueRS-D120002
- FormulaC7H5F4NO4S2
- MW307.24
CUSTOM SYNTHESIS
On this page
![Chemical structure of 4-Fluoro-3-[(trifluoromethyl)sulfonyl]benzenesulfonamide](/structures/w4/JOESWBMGEGYULU-UHFFFAOYSA-N.webp?v=8)
Product identification
| Product name | 4-Fluoro-3-[(trifluoromethyl)sulfonyl]benzenesulfonamide |
|---|---|
| Catalogue No. | RS-D120002 |
| CAS No. | 1027345-08-9 |
| Molecular formula | C7H5F4NO4S2 |
| Molecular weight | 307.24 |
| Availability | Custom synthesis— made to order, typically 3–4 weeks |
| Standard type | Drug Metabolite Standards |
| Drug substance | Celecoxib |
| Storage | 2-8°C Refrigerator |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-D120002 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
A certificate of analysis (COA) is issued for the lot you receive. It records the catalogue number
RS-D120002 and the batch number, the tests performed, the
specification applied and the result obtained. A safety data sheet is supplied with the shipment.
Is the assigned value given on an “as is” basis?
Content and purity are stated per lot on the certificate of analysis, on an “as is” basis unless the certificate says otherwise. The analytical basis for the assigned value is stated on the certificate.
How should this material be stored?
Store as stated: 2-8°C Refrigerator. Re-test before use beyond the retest date printed on the certificate.
Do you supply pack sizes other than those listed?
Pack sizes are confirmed with the quotation. Quantities beyond the standard pack sizes can be quoted — send the quantity you need with your enquiry.
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Celecoxib
- Drug Metabolite Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-D120002
- Request a quotation for RS-D120002
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Celecoxib
All 100 further standards are listed here — every link is in the page, not loaded later.
-
Celecoxib
IN STOCKRS-I002063 -
CELECOXIB
CUSTOM SYNTHESISRS-Z412NDQ -
Celecoxib Impurity 93 (Celecoxib USP Related Compound D)
IN STOCKRS-C059055 -
Celecoxib-Impurity A
IN STOCKRS-C059008 -
(4-Sulfamoylphenyl)hydrazine-d4 Hydrochloride
IN STOCKRS-Z400PBX -
1,1,1-Trifluoro-4-methoxy-4-(4-methylphenyl)-3-buten-2-one
IN STOCKRS-P010544 -
1,5-Hexadiene
IN STOCKRS-U015A2F -
1,6-dimethyl-N-(4-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinamine
IN STOCKRS-Z401JMR -
1-(2-Fluorophenyl)-3-methyl-1H-pyrazole5-carboxylic acid
IN STOCKRS-Z412PD7 -
1-(3-Chlorophenyl)-3-methyl-4-[3-(trifluoromethyl)phenyl]-1H-pyrazol-5-amine
IN STOCKRS-P001105 -
2,5-Dimethyl Celecoxib-d4
CUSTOM SYNTHESISRS-C059030 -
2,5-Dimethyl-celecoxib
IN STOCKRS-I010087 -
2-(Aminooxy)-2-methylpropanoic acid hydrochloride
IN STOCKRS-Z401LXB -
2-hydrazinylbenzene-1-sulfonamide
IN STOCKRS-Z401M0C -
3-(p-Tolyl)-5-(trifluoromethyl)-1H-pyrazole
IN STOCKRS-Z412OHU -
3-Methyl-5-p-tolyl-1H-pyrazole
CUSTOM SYNTHESISRS-D128141 -
4-(5-(2,5-Dimethylphenyl)-1-methyl-1H-pyrazol-3-yl)phenol
CUSTOM SYNTHESISRS-Z401IBC -
4-Desmethyl-3-methyl Celecoxib-d4
IN STOCKRS-C059032 -
4-Ethyltoluene
IN STOCKRS-U001216 -
4-Hydrazino Benzene Sulfonamide Hydrochloride
IN STOCKRS-Z412PKJ -
4-Hydrazinobenzene-1-sulfonamide hydrochloride
IN STOCKRS-C007014 -
4-Nitrobenzenesulfonic Acid
IN STOCKRS-U002490 -
Benzenesulfonamide, 4-[2-(1-phenylethylidene)hydrazinyl]-
IN STOCKRS-I012305 -
Benzenesulfonamide,3-hydrazino-
IN STOCKRS-Z397BPF -
Celecoxib Carboxylic Acid
IN STOCKRS-I002064 -
Celecoxib Carboxylic Acid-Acyl-beta-D-Glucuronide
BACK ORDERRS-I002310 -
Celecoxib D4
IN STOCKRS-C059043 -
Celecoxib Ethyl Ester
BACK ORDERRS-C059015 -
Celecoxib Hydroxymethyl Analog
IN STOCKRS-Z001GED -
Celecoxib Impurity (N-Acetyl-4-(2-Aminoethyl)-Benzenesulfonamide)
IN STOCKRS-I002339 -
Celecoxib Methyl Ester
CUSTOM SYNTHESISRS-C059014 -
Celecoxib Peroxide
IN STOCKRS-C059013 -
Celecoxib-d3
IN STOCKRS-C059058 -
Celecoxib-d7
IN STOCKRS-I098409 -
Desaryl Celecoxib
IN STOCKRS-C059026 -
Diallylamine Hydrochloride
BACK ORDERRS-U077831 -
Ethyl 2,2,2-Trifluoroacetate
IN STOCKRS-U211MYM -
Ethyl acetamidobenzenesulfonate
CUSTOM SYNTHESISRS-U064177 -
Isopropyl acetamidobenzenesulfonate
IN STOCKRS-U061327 -
Methyl 2,2,2-Trifluoroacetate
IN STOCKRS-U088809 -
MK-886 Sodium Salt
CUSTOM SYNTHESISRS-D128014 -
N-(2-bromophenyl)nitrous amide
IN STOCKRS-U057165 -
N-De(4-sulfonamidophenyl)-N'-[4-sulfonamido(phenyl-d4)] Celecoxib
IN STOCKRS-C059031 -
RS-Z401K71
CUSTOM SYNTHESISRS-Z401K71 -
p-Methylacetophenone Dimethyl Acetal
IN STOCKRS-P1248004 -
Propylamine Hydrochloride
IN STOCKRS-U084531 -
Trifluoroacetic acid
IN STOCKRS-U087391 -
64
CUSTOM SYNTHESISRS-Z401GCX -
Celecoxib Impurity 2
IN STOCKRS-C059007 -
Celecoxib Impurity 3
IN STOCKRS-C059009 -
Celecoxib Impurity 4
CUSTOM SYNTHESISRS-C059006 -
Celecoxib Impurity 7
IN STOCKRS-C059001 -
Celecoxib Impurity 8
IN STOCKRS-C059025 -
Celecoxib Impurity 9
IN STOCKRS-C059020 -
Celecoxib Impurity 16
CUSTOM SYNTHESISRS-C059049 -
Celecoxib Impurity 23
IN STOCKRS-C059021 -
Celecoxib Impurity 27
IN STOCKRS-C059059 -
Celecoxib Impurity 29
IN STOCKRS-C059022 -
Celecoxib Impurity 32
IN STOCKRS-C059024 -
Celecoxib Impurity 36
IN STOCKRS-C059004 -
Celecoxib Impurity 40
IN STOCKRS-C059010 -
Celecoxib Impurity 53
BACK ORDERRS-C059028 -
Celecoxib Impurity 56
BACK ORDERRS-C059053 -
Celecoxib Impurity 56
CUSTOM SYNTHESISRS-Z401IXX -
Celecoxib Impurity 61 (N-Nitroso Celecoxib Impurity 36)
IN STOCKRS-C059038 -
Celecoxib Impurity 62
IN STOCKRS-C059045 -
Celecoxib Impurity 64 (N-Nitroso Aniline)
IN STOCKRS-C059041 -
Celecoxib Impurity 66
BACK ORDERRS-I001850 -
Celecoxib Impurity 67
IN STOCKRS-C059052 -
Celecoxib Impurity 68
CUSTOM SYNTHESISRS-C059047 -
Celecoxib Impurity 69
IN STOCKRS-C059056 -
Celecoxib Impurity 70
IN STOCKRS-C059044 -
Celecoxib Impurity 81
IN STOCKRS-C059048 -
Celecoxib Impurity 87
IN STOCKRS-I001038 -
Celecoxib Impurity 96
CUSTOM SYNTHESISRS-C059023 -
Celecoxib Impurity 97
IN STOCKRS-C059039 -
Celecoxib Impurity 98
CUSTOM SYNTHESISRS-C059050 -
Celecoxib Impurity 99
CUSTOM SYNTHESISRS-C059063 -
Celecoxib Impurity 114
IN STOCKRS-C059002 -
Celecoxib Impurity 115
IN STOCKRS-C059003 -
Celecoxib Impurity 116
CUSTOM SYNTHESISRS-C059005 -
Celecoxib Impurity 117
IN STOCKRS-C059011 -
Celecoxib Impurity 118
BACK ORDERRS-C059016 -
Celecoxib Impurity 119
IN STOCKRS-C059018 -
Celecoxib Impurity 120
IN STOCKRS-C059019 -
Celecoxib Impurity 121
IN STOCKRS-C059027 -
Celecoxib Impurity 122
CUSTOM SYNTHESISRS-C059033 -
Celecoxib Impurity 123
BACK ORDERRS-C059034 -
Celecoxib Impurity 124
IN STOCKRS-C059035 -
Celecoxib Impurity 125
IN STOCKRS-C059036 -
Celecoxib Impurity 127
CUSTOM SYNTHESISRS-C059040 -
Celecoxib Impurity 128
IN STOCKRS-C059042 -
Celecoxib Impurity 129
IN STOCKRS-C059046 -
Celecoxib Impurity 130
IN STOCKRS-C059051 -
Celecoxib Impurity 131
IN STOCKRS-C059054 -
Celecoxib Impurity 132
IN STOCKRS-C059057 -
Celecoxib Impurity 166
IN STOCKRS-U003243 -
Celecoxib Impurity 167
IN STOCKRS-U010366
![Chemical structure of 1,6-dimethyl-N-(4-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinamine](/structures/w4/CWILMKDSVMROHT-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 1-(3-Chlorophenyl)-3-methyl-4-[3-(trifluoromethyl)phenyl]-1H-pyrazol-5-amine](/structures/w4/XLNMLURMBNWWLN-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 4-[[(1R)-3-(4-Morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-trifluoromethylsulfonyl-benzenesulfonamide](/structures/w4/WDHCLDUKGHLEOU-MRXNPFEDSA-N.webp?v=8)
![Chemical structure of 4-[[(1R)-3-(4-Morpholinyl)-3-oxo-1-[(phenylthio)methyl]propyl]amino]-3-trifluoromethylsulfonyl-benzenesulfonamide](/structures/w4/FVVGOJKXBWLQFS-OAHLLOKOSA-N.webp?v=8)
![Chemical structure of Benzenesulfonamide, 4-[2-(1-phenylethylidene)hydrazinyl]-](/structures/w4/PUVSHVDTTMRGCX-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of N-De(4-sulfonamidophenyl)-N'-[4-sulfonamido(phenyl-d4)] Celecoxib](/structures/w4/LGIMTMFJBCXYRP-YKVCKAMESA-N.webp?v=8)
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.